Received Mar 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | — | IM / RA |
| MENB | MENINGOCOCCAL B (TRUMENBA) | PFIZER\WYETH | UNK | — | ID / LA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | — | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | IM / RA |
Patient had a syncopal episode immediatly after vaccinations. Possible vagul response. Patient hypotensive, diaphoretic, and pale. Patient was able to recover within 10-15 minutes. Paramedics were called. Patient EKG showed sinus arrythmia. Blood sugar 101. BP was unmeasurable immediately after incident but eventually went up to 80/60, then 90/70. Patient declined to go with paramedics, and was feeling better, color returned, BP improved, able to stand and safely leave clinic with her husband.
none
Possible POTS, Anxiety
none
none
Accucheck 101